Overview

Efficacy and Safety of Adalimumab in Patients With Active Uveitis

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
A study comparing the safety and efficacy of adalimumab compared with placebo in patients with active uveitis.
Phase:
Phase 3
Details
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Treatments:
Adalimumab
Prednisone